Detalles de la búsqueda
1.
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry.
Br J Cancer
; 119(10): 1233-1243, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30385821
2.
Translational reprogramming following UVB irradiation is mediated by DNA-PKcs and allows selective recruitment to the polysomes of mRNAs encoding DNA repair enzymes.
Genes Dev
; 23(10): 1207-20, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19451221
3.
ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib.
Cancer Res
; 82(6): 1140-1152, 2022 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35078817
4.
Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells.
Oncogene
; 39(25): 4869-4883, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444694
5.
Modeling Dose and Schedule Effects of AZD2811 Nanoparticles Targeting Aurora B Kinase for Treatment of Diffuse Large B-cell Lymphoma.
Mol Cancer Ther
; 18(5): 909-919, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30872381
6.
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress.
Cancer Res
; 79(14): 3762-3775, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31123088
7.
Paclitaxel decreases the accumulation of gemcitabine and its metabolites in human leukemia cells and primary cell cultures.
Anticancer Res
; 25(6B): 4165-71, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16309212
Resultados
1 -
7
de 7
1
Próxima >
>>